Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis

Published:2024-01-25 Issue:1 Volume:56 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Xu Xiangbo¹²³,Gao Fangbo¹²,Wang Ting¹²,Yang Zuyao⁴,Zhao Qingchun¹³,Qi Xingshun¹²

Affiliation:

1. Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, China

2. Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China

3. Department of Pharmacy, General Hospital of Northern Theater Command, Shenyang, China

4. Division of Epidemiology, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2024.2305935

Reference57 articles.

1. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases

2. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

3. Baveno VII – Renewing consensus in portal hypertension

4. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

5. Non‐selective beta‐blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infection

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ascites in cirrhotic patients: a comprehensive review;Exploration of Digestive Diseases;2024-08-26

2. Non-Selective Beta-Blockers in Patients with Cirrhosis: Current Evidence and Controversy;Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management;2024-06-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3